NEFAZODONE HYDROCHLORIDE vs TRAZODONE HCL

Compare NEFAZODONE HYDROCHLORIDE (Nefazodone Hydrochloride) and TRAZODONE HCL (Trazodone HCL) — clinical data, side effects, and patient experiences.

NEFAZODONE HYDROCHLORIDE

Nefazodone Hydrochloride · Atypical Antidepressant

How it works

Pharmacodynamics The mechanism of action of nefazodone, as with other antidepressants, is unknown. Preclinical studies have shown that nefazodone inhibits neuronal uptake of seroto...

Approved for

INDICATIONS AND USAGE Nefazodone hydrochloride tablets are indicated for the treatment of depression. When deciding among the alternative treatments available for this condition

the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride treatment (see WARNINGS ). In many cases

loss of interest in usual activities

significant change in weight and/or appetite

OralTablet

TRAZODONE HCL

Trazodone HCL · Atypical Antidepressant

How it works

Other agent

Approved for

Trazodone hydrochloride tablets

USP are indicated for the treatment of major depressive disorder (MDD) in adults.

OralTablet

Quick Comparison

NEFAZODONE HYDROCHLORIDETRAZODONE HCL

Drug Class

Atypical Antidepressant

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

NEFAZODONE HYDROCHLORIDE

Depression

>10%

Drug Not Working

1-10%

Insomnia

1-10%

Anxiety

1-10%

Nausea

1-10%

Headache

0.1-1%

Weight Loss

0.1-1%

TRAZODONE HCL

Drug Not Working

>10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Insomnia

1-10%

Depression

1-10%

FDA Warnings

NEFAZODONE HYDROCHLORIDE

Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders
Anyone considering the use of nefazodone hydrochloride tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide

TRAZODONE HCL

The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St
The concomitant use of trazodone with MAOIs is contraindicated
If concomitant use of trazodone with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms
Trazodone should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval

Clinical Trial Data

No head-to-head clinical studies found for NEFAZODONE HYDROCHLORIDE vs TRAZODONE HCL.

NEFAZODONE HYDROCHLORIDE vs TRAZODONE HCL: What You Should Know

Key Differences

Both NEFAZODONE HYDROCHLORIDE and TRAZODONE HCL belong to the Atypical Antidepressant class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

NEFAZODONE HYDROCHLORIDE carries 4 FDA warnings. TRAZODONE HCL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

NEFAZODONE HYDROCHLORIDE vs VILAZODONE HYDROCHLORIDE→TRAZODONE HCL vs VILAZODONE HYDROCHLORIDE→MIRTAZAPINE vs NEFAZODONE HYDROCHLORIDE→NEFAZODONE HYDROCHLORIDE vs VORTIOXETINE→NEFAZODONE HYDROCHLORIDE vs TRAZODONE HYDROCHLORIDE→NEFAZODONE HYDROCHLORIDE vs TRAZODONE HYDROCHLORIDE ORAL→

Loading comparison data...

NEFAZODONE HYDROCHLORIDE vs TRAZODONE HCL

Compare NEFAZODONE HYDROCHLORIDE (Nefazodone Hydrochloride) and TRAZODONE HCL (Trazodone HCL) — clinical data, side effects, and patient experiences.

NEFAZODONE HYDROCHLORIDE

Nefazodone Hydrochloride · Atypical Antidepressant

How it works

Pharmacodynamics The mechanism of action of nefazodone, as with other antidepressants, is unknown. Preclinical studies have shown that nefazodone inhibits neuronal uptake of seroto...

Approved for

INDICATIONS AND USAGE Nefazodone hydrochloride tablets are indicated for the treatment of depression. When deciding among the alternative treatments available for this condition

the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride treatment (see WARNINGS ). In many cases

loss of interest in usual activities

significant change in weight and/or appetite

OralTablet

TRAZODONE HCL

Trazodone HCL · Atypical Antidepressant

How it works

Other agent

Approved for

Trazodone hydrochloride tablets

USP are indicated for the treatment of major depressive disorder (MDD) in adults.

OralTablet

Quick Comparison

NEFAZODONE HYDROCHLORIDETRAZODONE HCL

Drug Class

Atypical Antidepressant

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

NEFAZODONE HYDROCHLORIDE

Depression

>10%

Drug Not Working

1-10%

Insomnia

1-10%

Anxiety

1-10%

Nausea

1-10%

Headache

0.1-1%

Weight Loss

0.1-1%

TRAZODONE HCL

Drug Not Working

>10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Insomnia

1-10%

Depression

1-10%

FDA Warnings

NEFAZODONE HYDROCHLORIDE

Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders
Anyone considering the use of nefazodone hydrochloride tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide

TRAZODONE HCL

The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St
The concomitant use of trazodone with MAOIs is contraindicated
If concomitant use of trazodone with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms
Trazodone should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval

Clinical Trial Data

No head-to-head clinical studies found for NEFAZODONE HYDROCHLORIDE vs TRAZODONE HCL.

NEFAZODONE HYDROCHLORIDE vs TRAZODONE HCL: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.